Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Beltran Lab
Explore this Website
Home
About Us
Toggle About Us menu options
Contact Us
Job Opportunities
Videos
Affiliations
Research
Lab Team
News
Publications
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Affiliations
Research
Lab Team
News
Publications
Home
Publications
Publications
Found 16 results
Author
Title
Type
Year
Filters:
Author
is
Demichelis, Francesca
[Clear All Filters]
2018
Armenia J
,
Wankowicz SAM
,
Liu D
,
Gao J
,
Kundra R
,
Reznik E
,
Chatila WK
,
Chakravarty D
,
G Han C
,
Coleman I
et al.
. 2018.
The long tail of oncogenic drivers in prostate cancer.
.
Nat Genet. 50(5):645-651.
Puca L
,
Bareja R
,
Prandi D
,
Shaw R
,
Benelli M
,
Karthaus WR
,
Hess J
,
Sigouros M
,
Donoghue A
,
Kossai M
et al.
. 2018.
Patient derived organoids to model rare prostate cancer phenotypes.
.
Nat Commun. 9(1):2404.
Beltran H
,
Oromendia C
,
Danila DC
,
Montgomery B
,
Hoimes C
,
Szmulewitz RZ
,
Vaishampayan U
,
Armstrong AJ
,
Stein M
,
Pinski J
et al.
. 2018.
A phase II trial of the aurora kinase A inhibitor alisertib for patients with castration resistant and neuroendocrine prostate cancer: efficacy and biomarkers.
.
Clin Cancer Res.
2017
Rickman DS
,
Beltran H
,
Demichelis F
,
Rubin MA
. 2017.
Biology and evolution of poorly differentiated neuroendocrine tumors.
.
Nat Med. 23(6):1-10.
Wilkes DC
,
Sailer V
,
Xue H
,
Cheng H
,
Collins CC
,
Gleave M
,
Wang Y
,
Demichelis F
,
Beltran H
,
Rubin MA
et al.
. 2017.
A germline FANCA alteration that is associated with increased sensitivity to DNA damaging agents.
.
Cold Spring Harb Mol Case Stud. 3(5)
Pisapia DJ
,
Salvatore S
,
Pauli C
,
Hissong E
,
Eng K
,
Prandi D
,
Sailer V-W
,
Robinson BD
,
Park K
,
Cyrta J
et al.
. 2017.
Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models.
.
JCO Precis Oncol. 2017
Pauli C
,
Hopkins BD
,
Prandi D
,
Shaw R
,
Fedrizzi T
,
Sboner A
,
Sailer V
,
Augello M
,
Puca L
,
Rosati R
et al.
. 2017.
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine.
.
Cancer Discov.
Mu P
,
Zhang Z
,
Benelli M
,
Karthaus WR
,
Hoover E
,
Chen C-C
,
Wongvipat J
,
Ku S-Y
,
Gao D
,
Cao Z
et al.
. 2017.
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer.
.
Science. 355(6320):84-88.
2015
Robinson D
,
Van Allen EM
,
Wu Y-M
,
Schultz N
,
Lonigro RJ
,
Mosquera J-M
,
Montgomery B
,
Taplin M-E
,
Pritchard CC
,
Attard G
et al.
. 2015.
Integrative clinical genomics of advanced prostate cancer.
.
Cell. 161(5):1215-28.
Beltran H
,
Demichelis F
. 2015.
Prostate cancer: Intrapatient heterogeneity in prostate cancer.
.
Nat Rev Urol. 12(8):430-1.
Beltran H
,
Eng K
,
Mosquera JMiguel
,
Sigaras A
,
Romanel A
,
Rennert H
,
Kossai M
,
Pauli C
,
Faltas B
,
Fontugne J
et al.
. 2015.
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
.
JAMA Oncol. 1(4):466-74.
2014
Prandi D
,
Baca SC
,
Romanel A
,
Barbieri CE
,
Mosquera J-M
,
Fontugne J
,
Beltran H
,
Sboner A
,
Garraway LA
,
Rubin MA
et al.
. 2014.
Unraveling the clonal hierarchy of somatic genomic aberrations.
.
Genome Biol. 15(8):439.
2013
Lin P-C
,
Chiu Y-L
,
Banerjee S
,
Park K
,
Mosquera JMiguel
,
Giannopoulou E
,
Alves P
,
Tewari AK
,
Gerstein MB
,
Beltran H
et al.
. 2013.
Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression.
.
Cancer Res. 73(3):1232-44.
Baca SC
,
Prandi D
,
Lawrence MS
,
Mosquera JMiguel
,
Romanel A
,
Drier Y
,
Park K
,
Kitabayashi N
,
MacDonald TY
,
Ghandi M
et al.
. 2013.
Punctuated evolution of prostate cancer genomes.
.
Cell. 153(3):666-77.
2012
Demichelis F
,
Setlur SR
,
Banerjee S
,
Chakravarty D
,
Chen JYun Helen
,
Chen CX
,
Huang J
,
Beltran H
,
Oldridge DA
,
Kitabayashi N
et al.
. 2012.
Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.
.
Proc Natl Acad Sci U S A. 109(17):6686-91.
Collins CC
,
Volik SV
,
Lapuk AV
,
Wang Y
,
Gout PW
,
Wu C
,
Xue H
,
Cheng H
,
Haegert A
,
Bell RH
et al.
. 2012.
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.
.
Mol Cancer Ther. 11(3):775-83.